BIOMAT Database Logo BIOMAT Database Logo

Lorcaserin Safety in Overweight or Obese Patients. 2019

Soo-Youn Ham, and Sang W Shin
Kangbuk Samsung Medical Center, Seoul, South Korea.

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D050177 Overweight A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".

Related Publications

Soo-Youn Ham, and Sang W Shin
Lorcaserin Safety in Overweight or Obese Patients.
January 2019, The New England journal of medicine,
Soo-Youn Ham, and Sang W Shin
Lorcaserin Safety in Overweight or Obese Patients.
January 2019, The New England journal of medicine,
Soo-Youn Ham, and Sang W Shin
Lorcaserin Safety in Overweight or Obese Patients.
January 2019, The New England journal of medicine,
Soo-Youn Ham, and Sang W Shin
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
September 2018, The New England journal of medicine,
Soo-Youn Ham, and Sang W Shin
In high-risk obese or overweight patients, lorcaserin did not increase or decrease CV events at 3.3 years.
December 2018, Annals of internal medicine,
Soo-Youn Ham, and Sang W Shin
Lorcaserin in Obese and Overweight Patients Taking Prohibited Serotonergic Agents: A Retrospective Analysis.
June 2016, Clinical therapeutics,
Soo-Youn Ham, and Sang W Shin
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
January 2019, Circulation,
Soo-Youn Ham, and Sang W Shin
Obese or overweight?
July 1968, Aerospace medicine,
Soo-Youn Ham, and Sang W Shin
Safety of liver resections in obese and overweight patients.
December 2010, World journal of surgery,
Soo-Youn Ham, and Sang W Shin
Blood lipids profile in obese or overweight patients.
January 2003, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
Copied contents to your clipboard!